Tailored Use of Avacopan in a Case With Refractory Antineutrophil Cytoplasmic Antibody-Associated Renal Vasculitis and Concominant Complement System Activation

Detalles Bibliográficos
Autores principales: Hakroush, Samy, Tampe, Björn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939350/
https://www.ncbi.nlm.nih.gov/pubmed/36815109
http://dx.doi.org/10.1016/j.ekir.2022.10.033
_version_ 1784890830760181760
author Hakroush, Samy
Tampe, Björn
author_facet Hakroush, Samy
Tampe, Björn
author_sort Hakroush, Samy
collection PubMed
description
format Online
Article
Text
id pubmed-9939350
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-99393502023-02-21 Tailored Use of Avacopan in a Case With Refractory Antineutrophil Cytoplasmic Antibody-Associated Renal Vasculitis and Concominant Complement System Activation Hakroush, Samy Tampe, Björn Kidney Int Rep Letter to the Editor Elsevier 2022-11-25 /pmc/articles/PMC9939350/ /pubmed/36815109 http://dx.doi.org/10.1016/j.ekir.2022.10.033 Text en © 2022 International Society of Nephrology. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Letter to the Editor
Hakroush, Samy
Tampe, Björn
Tailored Use of Avacopan in a Case With Refractory Antineutrophil Cytoplasmic Antibody-Associated Renal Vasculitis and Concominant Complement System Activation
title Tailored Use of Avacopan in a Case With Refractory Antineutrophil Cytoplasmic Antibody-Associated Renal Vasculitis and Concominant Complement System Activation
title_full Tailored Use of Avacopan in a Case With Refractory Antineutrophil Cytoplasmic Antibody-Associated Renal Vasculitis and Concominant Complement System Activation
title_fullStr Tailored Use of Avacopan in a Case With Refractory Antineutrophil Cytoplasmic Antibody-Associated Renal Vasculitis and Concominant Complement System Activation
title_full_unstemmed Tailored Use of Avacopan in a Case With Refractory Antineutrophil Cytoplasmic Antibody-Associated Renal Vasculitis and Concominant Complement System Activation
title_short Tailored Use of Avacopan in a Case With Refractory Antineutrophil Cytoplasmic Antibody-Associated Renal Vasculitis and Concominant Complement System Activation
title_sort tailored use of avacopan in a case with refractory antineutrophil cytoplasmic antibody-associated renal vasculitis and concominant complement system activation
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939350/
https://www.ncbi.nlm.nih.gov/pubmed/36815109
http://dx.doi.org/10.1016/j.ekir.2022.10.033
work_keys_str_mv AT hakroushsamy tailoreduseofavacopaninacasewithrefractoryantineutrophilcytoplasmicantibodyassociatedrenalvasculitisandconcominantcomplementsystemactivation
AT tampebjorn tailoreduseofavacopaninacasewithrefractoryantineutrophilcytoplasmicantibodyassociatedrenalvasculitisandconcominantcomplementsystemactivation

Ejemplares similares